May. 13 at 6:53 PM
$GDRX
$HIMS is building a real consumer healthcare platform.
$GDRX still looks like a prescription coupon middleman trying to reinvent itself.
Hims owns:
* the patient relationship
* telehealth
* prescribing
* subscriptions
* fulfillment
* recurring engagement
That’s a much stronger long-term model than relying on pharmacy transaction fees.
Meanwhile:
*
$HIMS continues putting up major growth
*
$GDRX user growth and subscriptions have been shrinking
* GoodRx revenue has largely stalled
Consumers want frictionless healthcare, not more coupon searching.
$HIMS feels like the future.
$GDRX feels like a utility layer that can get commoditized.
This is why people are short GDRX.
